ACXP vs. QTUM
ACXP (Acurx Pharmaceuticals, Inc.) is a stock, while QTUM (Defiance Quantum ETF) is Technology Equities fund tracking the BlueStar Machine Learning and Quantum Computing Index. Over the past 5 years, ACXP returned -61.02%/yr vs 27.89%/yr for QTUM. At a 0.17 correlation, their price movements are largely independent.
Performance
ACXP vs. QTUM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ACXP achieves a -42.97% return, which is significantly lower than QTUM's 46.66% return.
ACXP
- 1D
- -3.40%
- 1M
- -26.80%
- YTD
- -42.97%
- 6M
- -58.96%
- 1Y
- -87.46%
- 3Y*
- -69.37%
- 5Y*
- -61.02%
- 10Y*
- —
QTUM
- 1D
- 0.22%
- 1M
- 1.19%
- YTD
- 46.66%
- 6M
- 44.23%
- 1Y
- 79.78%
- 3Y*
- 50.10%
- 5Y*
- 27.89%
- 10Y*
- —
ACXP vs. QTUM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ACXP Acurx Pharmaceuticals, Inc. | -42.97% | -84.71% | -78.75% | -3.77% | -7.90% | -27.37% |
QTUM Defiance Quantum ETF | 46.66% | 36.65% | 50.54% | 39.86% | -28.80% | 13.88% |
Correlation
The correlation between ACXP and QTUM is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jun 25, 2021 | 0.17 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ACXP vs. QTUM — Risk / Return Rank
ACXP
QTUM
ACXP vs. QTUM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Acurx Pharmaceuticals, Inc. (ACXP) and Defiance Quantum ETF (QTUM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ACXP | QTUM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.22 | ||
| Sortino ratioReturn per unit of downside risk | -4.23 | ||
| Omega ratioGain probability vs. loss probability | 0.90 | 1.44 | -0.53 |
| Calmar ratioReturn relative to maximum drawdown | -1.01 | 5.26 | -6.26 |
| Martin ratioReturn relative to average drawdown | -1.37 | 18.84 | -20.20 |
Loading charts...
Drawdowns
ACXP vs. QTUM - Drawdown Comparison
The maximum ACXP drawdown since its inception was -99.14%, which is greater than QTUM's maximum drawdown of -38.45%. Use the drawdown chart below to compare losses from any high point for ACXP and QTUM.
Loading charts...
Drawdown Indicators
| ACXP | QTUM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.14% | -38.45% | -60.69% |
Max Drawdown (1Y)Largest decline over 1 year | -86.79% | -15.26% | -71.53% |
Max Drawdown (3Y)Largest decline over 3 years | -98.83% | -25.39% | -73.44% |
Max Drawdown (5Y)Largest decline over 5 years | -99.14% | -38.45% | -60.69% |
Current DrawdownCurrent decline from peak | -99.10% | -4.89% | -94.21% |
Average DrawdownAverage peak-to-trough decline | -69.58% | -8.22% | -61.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 66.94% | 4.25% | +62.69% |
Volatility
ACXP vs. QTUM - Volatility Comparison
The current volatility for Acurx Pharmaceuticals, Inc. (ACXP) is 13.34%, while Defiance Quantum ETF (QTUM) has a volatility of 14.51%. This indicates that ACXP experiences smaller price fluctuations and is considered to be less risky than QTUM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ACXP | QTUM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.34% | 14.51% | -1.17% |
Volatility (6M)Calculated over the trailing 6-month period | 119.86% | 23.72% | +96.14% |
Volatility (1Y)Calculated over the trailing 1-year period | 188.03% | 29.11% | +158.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 140.08% | 27.18% | +112.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 140.79% | 27.47% | +113.32% |
Dividends
ACXP vs. QTUM - Dividend Comparison
ACXP has not paid dividends to shareholders, while QTUM's dividend yield for the trailing twelve months is around 0.73%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
ACXP Acurx Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
QTUM Defiance Quantum ETF | 0.73% | 1.01% | 0.61% | 0.81% | 1.46% | 0.48% | 0.42% | 0.61% | 0.21% |
Frequently Asked Questions
ACXP and QTUM have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QTUM has higher volatility (14.51%) compared to ACXP (13.34%). In terms of maximum drawdown, ACXP dropped -99.14% vs QTUM's -38.45%.
QTUM currently has the higher Sharpe Ratio (2.76 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ACXP and QTUM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer